Fluoromisonidazole in a Rat Model of Ischemic Stroke

Background and Purpose—The ischemic penumbra is a major focus of stroke research. F-fluoromisonidazole (F-FMISO), a positron emission tomography (PET) marker of hypoxic cells, has shown promise as a technique to image the penumbra in humans. Our aim was to delineate the pattern of F-FMISO binding in a rat middle cerebral artery transient thread-occlusion model, and correlate this with tissue outcome at 24 hours. We hypothesized that the pattern of F-FMISO binding would mimic that seen in humans. Methods—Thirty-eight rats underwent 2 hours transient middle cerebral artery (MCA) occlusion, and then received F-FMISO at time points from 0.5 to 22 hours post-MCA occlusion and were killed 2 hours later. Autoradiographic assessment of F-FMISO binding and assessment (triphenyltetrazolium chloride) of the area of infarction were performed on tissue slices. Results—Until 1 hour after MCA occlusion, F-FMISO binding was increased in the entire MCA territory, with little or no infarction visible. Over the next 5 hours, the pattern of binding evolved to a small rim of intensely binding tissue surrounding the infarct core, which itself showed reduced binding compared with the contralateral hemisphere. By 24 hours, there was minimal accumulation of F-FMISO binding and a large area of infarction. Conclusions—The pattern of F-FMISO binding rats reproduced the pattern seen in humans, consistent with this tracer being a marker of the ischemic penumbra in both species. This technique may have application in studying the ischemic penumbra in animal models, and correlating this with similar studies in humans. (Stroke. 2004;35:000-000.)

[1]  V Beaudouin,et al.  Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. , 1996, Stroke.

[2]  W D Heiss,et al.  Ischemic Penumbra: Evidence From Functional Imaging in Man , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  M D Ginsberg,et al.  Transient Middle Cerebral Artery Occlusion by Intraluminal Suture: II. Neurological Deficits, and Pixel-Based Correlation of Histopathology with Local Blood Flow and Glucose Utilization , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  G. Mies,et al.  Ischemic Thresholds of Cerebral Protein Synthesis and Energy State following Middle Cerebral Artery Occlusion in Rat , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  J. Garcìa,et al.  Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. , 1995, Stroke.

[6]  D. Han,et al.  Limitations of tetrazolium salts in delineating infarcted brain , 2004, Acta Neuropathologica.

[7]  A. Nunn,et al.  Nitroimidazoles for imaging hypoxic myocardium , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[8]  D. Abbott,et al.  Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole , 1998, Neurology.

[9]  J. Garcìa,et al.  Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. , 1995, Stroke.

[10]  A. Nunn,et al.  Nitroimidazoles and imaging hypoxia , 1995, European Journal of Nuclear Medicine.

[11]  David J. Yang,et al.  Rapid Synthesis of 3-[18F]Fluoro-l-(2′-Nitro-1′-Imidazolyl)-2-Propanol ([18F]Fluoromisonidazole) , 1994, Pharmaceutical Research.

[12]  Jean-Claude Baron,et al.  Mapping the Ischaemic Penumbra with PET: Implications for Acute Stroke Treatment , 1999, Cerebrovascular Diseases.

[13]  J. Baron,et al.  Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. , 1995, Stroke.

[14]  T K Lewellen,et al.  Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.

[15]  V Beaudouin,et al.  Sequential studies of severely hypometabolic tissue volumes after permanent middle cerebral artery occlusion. A positron emission tomographic investigation in anesthetized baboons. , 1995, Stroke.

[16]  H J Tochon-Danguy,et al.  The fate of hypoxic tissue on 18F‐fluoromisonidazole positron emission tomography after ischemic stroke , 2000, Annals of neurology.

[17]  J. D. Chapman,et al.  Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro. , 1982, International journal of radiation oncology, biology, physics.

[18]  B. Siesjö,et al.  Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.

[19]  J. Baron,et al.  Mapping the ischaemic penumbra with PET: a new approach. , 2001, Brain : a journal of neurology.

[20]  D C Reutens,et al.  Topography and Temporal Evolution of Hypoxic Viable Tissue Identified by 18F-Fluoromisonidazole Positron Emission Tomography in Humans After Ischemic Stroke , 2003, Stroke.

[21]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.

[22]  S. Jasko,et al.  Therapy , 1881, The American journal of dental science.

[23]  K. Kogure,et al.  Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. , 1989, Stroke.

[24]  L. Pitts,et al.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.

[25]  T W Griffin,et al.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. , 1992, International journal of radiation oncology, biology, physics.

[26]  M Fisher,et al.  Characterizing the target of acute stroke therapy. , 1997, Stroke.

[27]  A. Hakim The Cerebral Ischemic Penumbra , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[28]  M. Lythgoe,et al.  Autoradiographic imaging of cerebral ischaemia using a combination of blood flow and hypoxic markers in an animal model , 2005, European Journal of Nuclear Medicine.

[29]  G. D. del Zoppo,et al.  Cerebral Microvessel Responses to Focal Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  K Wienhard,et al.  Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  J. Baron,et al.  Perfusion Thresholds in Human Cerebral Ischemia: Historical Perspective and Therapeutic Implications , 2001, Cerebrovascular Diseases.

[32]  Fausto Viader,et al.  Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra , 1996, Annals of neurology.

[33]  M. Lythgoe,et al.  The relationship between magnetic resonance diffusion imaging and autoradiographic markers of cerebral blood flow and hypoxia in an animal stroke model , 1999, Magnetic resonance in medicine.

[34]  M D Ginsberg,et al.  Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. , 1996, Stroke.